All Updates

All Updates

icon
Filter
Regulation/policy
FDA approval
Solar Foods obtains self-affirmed GRAS status for Solein in US
Plant-based Meat
Sep 2, 2024
This week:
Product updates
Hexagon unveils Advanced Compensation for metal 3D printing
Additive Manufacturing
Yesterday
Funding
Eden AI raises EUR 3 million in seed funding to accelerate product development
Generative AI Infrastructure
Nov 21, 2024
M&A
Wiz acquires Dazz to expand cloud security remediation capabilities
Next-gen Cybersecurity
Nov 21, 2024
Partnerships
Immutable partners with Altura to enhance Web3 game development and marketplace solutions
Web3 Ecosystem
Nov 21, 2024
Funding
OneCell Diagnostics raises USD 16 million in Series A funding to enhance cancer diagnostics
Precision Medicine
Nov 21, 2024
Partnerships
BioLineRx and Ayrmid partner to license and commercialize APHEXDA across multiple indications
Precision Medicine
Nov 21, 2024
Product updates
SOPHiA GENETICS announces global launch of MSK-IMPACT powered with SOPHiA DDM
Precision Medicine
Nov 21, 2024
Product updates
Biofidelity launches Aspyre Clinical Test for lung cancer detection
Precision Medicine
Nov 21, 2024
Partnerships
Spendesk partners with Adyen to enhance SMB spend management with banking-as-a-service solution
Business Expense Management
Nov 21, 2024
M&A
Mews acquires Swedish RMS provider Atomize to enhance Hospitality Cloud platform
Travel Tech
Nov 21, 2024
Plant-based Meat

Plant-based Meat

Sep 2, 2024

Solar Foods obtains self-affirmed GRAS status for Solein in US

Regulation/policy
FDA approval

  • Solar Foods, an alternative protein ingredient startup, has obtained self-affirmed Generally Recognized as Safe (GRAS) status in the US for its Solein protein ingredient, marking a significant step toward its commercialization and entry into the US market.

  • The next steps for Solar Foods include registering its production facility with the FDA, starting food exports to the US, and aiming to obtain "notified" GRAS status by receiving a "No Questions Letter" from the FDA by the end of 2026.

  • Solar Foods has also filed for novel food regulatory approvals for Solein in the UK and the EU and sees the US GRAS status as potentially contributing to expansion into other markets without specific novel food approvals, such as Japan.

  • Analyst QuickTake: Solar Foods has had an active year, marked by significant developments such as the launching of the world’s first air protein factory, securing USD 8.6 million in Series B funding, and launching products through its partnership with Ajinomoto. The GRAS status will further validate the safety of Solein, which has already demonstrated its commercial viability in the Singaporean market.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.